Search for: "Johnson " Results 8121 - 8140 of 36,430
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Apr 2012, 5:00 am
Blog readers are aware that in August of 2010, DePuy Orthopaedics, a Johnson & Johnson company, recalled certain ASR metal-on-metal hip implant devices that had been given to as many as 93,000 medical patients worldwide. [read post]
12 Sep 2016, 7:48 am by Law Offices of Jeffrey S. Glassman
The makes of Xarelto (Bayer and Johnson & Johnson) took a major hit this week in terms of the future of there flagship drug. [read post]
15 Jan 2020, 3:01 am by Liz Dunshee
Last year, John blogged about a shareholder proposal submitted to Johnson & Johnson dealing with a mandatory arbitration bylaw. [read post]
6 Oct 2015, 9:38 am by Ronald V. Miller, Jr.
 A Texas jury yesterday found for Johnson & Johnson’s (J&J) Ethicon division in a pelvic mesh claim. [read post]
25 Mar 2016, 10:24 am by Law Offices of Jeffrey S. Glassman
A recent feature from CBS News examined whether Johnson & Johnson and Bayer, the makers of Xarelto, knowingly withheld certain important data for a letter to be published in the New England Journal of Medicine. [read post]
4 Dec 2020, 11:20 am by anne
The settling defendants included Johnson & Johnson subsidiary Medical Device Business Services, Inc. and The Gores Group, a private equity firm that acquired Therakos from J&J in 2012. [read post]
11 Dec 2010, 7:10 am
In August 2010, Johnson & Johnson subsidiary, DePuy, announced a recall of its ASR XL Acetabular System and ASR Hip Resurfacing System, two hip replacement components used in total hip replacement surgery. [read post]
5 May 2016, 6:31 am by Law Offices of Jeffrey S. Glassman
Janssen, which is a division of pharmaceutical giant Johnson & Johnson, is the U.S. marketing partner of Bayer, the German drugmaker that manufactures Xarelto, and has released a report that its new oral anticoagulant (NOAC) is superior to Warfarin (Coumadin) in reducing the risk of ischemic stroke, according to a recent news feature from Cardiovascular Business. [read post]
5 Dec 2011, 4:00 am
The Chicago DePuy hip recall lawyers at our firm have often written about the problem with the Johnson & Johnson metal on metal hip designs. [read post]
22 Nov 2022, 7:22 am by Geoff Schweller
CFTC Commissioner Kristin Johnson told Bloomberg “in the context of the digital-asset space, the value of having those vocal whistleblowers and tipsters is critical. [read post]
25 Jul 2008, 7:40 pm
Lawrence, Jackson, Anderson, and Johnson (ND Ind., Judge Lozano) - a 13-page opinion, Judge Tinder writes:This case involves the consolidated appeals of Francis Lawrence, Anthony Jackson, David Anderson, and Leon Johnson, who filed motions with the district court to reduce their sentences under the retroactive sentencing guideline reductions for crack cocaine offenses. [read post]
6 Jun 2014, 8:27 am by Dr. Shezad Malik
Johnson & Johnson and its Ethicon subsidiary are exposed to more than 17,500 Ethicon pelvic mesh lawsuits in the federal court system. [read post]
22 Feb 2016, 5:59 am by Law Offices of Jeffrey S. Glassman
Xarelto, with a generic name rivaroxaban, is making hundreds of millions of dollars for Beyer and Janssen (a wholly owned Johnson & Johnson subsidiary), and these companies will take any chance they can get to increased sales. [read post]
24 Dec 2016, 7:58 am by Law Offices of Jeffrey S. Glassman
According to a recent news article from the Cook County Record, a woman has just filed a lawsuit against Bayer and Johnson & Johnson/Janssen Pharmaceuticals, who are the makers and U.S. marketing partners of the New Oral Anticoagulant (NOAC) Xarelto. [read post]
30 Dec 2016, 6:28 am by Law Offices of Jeffrey S. Glassman
  Janssen Research and Development was formerly known as Johnson and Johnson Pharmaceuticals Research and is still a wholly owned subsidiary of the pharmaceutical giant. [read post]
23 Jan 2016, 6:43 am by Law Offices of Jeffrey S. Glassman
Topamax, manufactured by Janssen Pharmaceutical (Johnson & Johnson) is known as an anticonvulsant medication. [read post]
12 Sep 2016, 7:48 am by Law Offices of Jeffrey S. Glassman
The makes of Xarelto (Bayer and Johnson & Johnson) took a major hit this week in terms of the future of there flagship drug. [read post]
22 Aug 2012, 11:13 am
Johnson & Johnson, a leading pharmaceutical and medical device manufacturer, as well as a prominent producer of personal care products, announced last week its plans to remove harmful substances, including formaldehyde from its consumer products. [read post]